JohnMRichartMD
Oncology • Saint Louis, MOAssociate Professor, Internal Medicine, St Louis University School of Medicine
Dr. Richart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3660 Vista
Saint Louis, MO 63110Phone+1 314-577-8854Fax+1 314-773-1167
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1999
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1993 - 1996
University of Missouri-Columbia School of MedicineClass of 1993
Certifications & Licensure
MO State Medical License 1996 - 2025
KS State Medical License 1999 - 2020
IL State Medical License 1999 - 2011- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01
- Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- 16 citationsHigh-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain MetastasesMelinda B Chu, Mark Fesler, Eric S. Armbrecht, Scott W. Fosko, Eddy C. Hsueh
Chemotherapy Research and Practice. 2013-05-13 - 17 citationsHeparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review.Mark Fesler, Michael H. Creer, John M. Richart, Randall C. Edgell, Necat Havlioglu
Neurocritical Care. 2011-08-01 - 17 citationsOxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient ObesityNiloufar Khojandi, Lindsey M. Kuehm, Alexander Piening, Maureen J. Donlin, Eddy C. Hsueh
Cancer Immunology Research. 2021-02-01
Press Mentions
New Therapy Improves Life Span in Melanoma Patients with Brain MetastasesJuly 31st, 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
